Irish Diagnostics Firm Altratech Aims to Enter Molecular, POC Testing Space by Supplanting PCR
The Ireland-based firm said its inexpensive capacitance-based assays deliver "molecular detection by proxy," providing rapid, multiplex, quantitative results.
The UK-based nanopore sequencing company's 2022 revenues were £198.6 million ($243.3 million), including £146.8 million from life science research tools.
LumiraDx Q4 Revenues Fall 65 Percent
The company was impacted by a $96.3 million accounting impairment due to excess manufacturing and inventory related to its COVID-19 test scale-up.
DiaSorin Gets FDA 510(k) for Molecular COVID-19/Flu Assay
The real-time RT-PCR Simplexa COVID-19 & Flu A/B Direct assay is designed for use on the company's Liaison MDX instrument, with results in about one hour.
The team applied its method, which uses isothermal amplification and bioluminescent proteins, to SARS-CoV-2 detection.